Chemtura (CHMT) Misses Q4 EPS by 2c

Chemtura (NYSE: CHMT) reported Q4 EPS of $0.10, $0.02 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $467 million versus the consensus estimate of $484.8 million.

For earnings history and earnings-related data on Chemtura (CHMT) click here.

You May Also Be Interested In

• Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
• Universal Health Realty (UHT) Reports Q1 EPS of $0.38
• First Bancshares (FBMS) Tops Q1 EPS by 6c